Signum Biosciences, Inc. Announces Collaborative Agreement with Glaxo... ( PRINCETON N.J. Nov. 10 2011 /- Signu...)

Signum Biosciences, Inc. Announces Collaborative Agreement with GlaxoSmithKline

Date:11/10/2011

PRINCETON, N.J., Nov. 10, 2011 /PRNewswire/ -- Signum Biosciences, Inc., a privately held biotechnology company, has entered into an agreement with GlaxoSmithKline (China) R&D Company Limited (GSK) to collaborate on Signum's phosphatase screening technology and Phosphoprotein Phosphatase 2A (PP2A).

The agreement provides Signum with research support and milestone payments. GSK receives the exclusive right of Signum's proprietary phosphatase screening technology for GSK's research and development activities in neurosciences.

GSK and Signum will undertake a broad R&D collaboration to screen and identify PP2A targeted compounds including those bridging the link between PP2A methylation and tau hyperphosphorylation. Signum's partnership with GSK furthers Signum's position as an innovative biotech company, advancing pioneering drug discovery and leveraging GSK's capabilities in research and development.

Maxwell Stock, President of Signum Biosciences, commented, "GSK is an ideal partner for Signum. We will develop therapeutics using our phosphatase screening technology in an alliance that utilizes the expertise of both companies. We are proud to be working in collaboration with a leading pharmaceutical company in innovative research and development. Collaborations such as these allow partners to share knowledge, expertise and resources and thereby provide a highly effective way of progressing cutting edge research and developing an effective drug."

About Signum Biosciences, Inc.

Signum, a Princeton, New Jersey- based biotechnology company, dedicated to developing small-molecule therapeutics derived from its Phosphatase platform to modulate signal transduction imbalances. Through research on protein networks that control biological systems, Signum is developing therapeutic agents for Alzheimer's, Parkinson's and other neurodegenerative diseases. Signum's technology provid
'/>"/>

SOURCE Signum Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine technology :

1. Signum Biosciences Awarded Two Additional NIH Grants for Development of Topical Therapeutics
2. Signum Biosciences, Inc. Announces Commercial Launch of Arazine™
3. Signum Biosciences Awarded Phase II SBIR Grant by the NIH for the Treatment of Rosacea
4. Regado Biosciences, Inc. to Present at the Sofinnova Japan Biopharma Partnering Conference in Tokyo, Japan
5. Luminex Corporation Completes Acquisition of EraGen Biosciences, Inc.
6. Luminex Corporation Announces Agreement to Acquire EraGen Biosciences, Inc.
7. Regado Biosciences, Inc. Presents Results of the RADAR Phase 2b Clinical Trial of its REG1 Anticoagulation System
8. Regado Biosciences, Inc. Announces Presentation of the Results of the RADAR Phase 2b Clinical Trial of Its Anticoagulant System REG1 at the i2 Summit During the American College of Cardiology 2011 60th Annual Scientific Session & Expo in New Orleans
9. Regado Biosciences, Inc. Introduces REG3, a Novel Aptamer-Based Inhibitor of Glycoprotein VI and its Matched Active Control Agent, at the American Heart Association (AHA) Scientific Sessions 2010 Meeting
10. Regado Biosciences, Inc. Presents Pharmacokinetic and Pharmacodynamic (PK/PD) Substudy Results From its Phase 2b RADAR Trial at the American Heart Association (AHA) Scientific Sessions 2010 Meeting
11. Regado Biosciences, Inc. Presents Two Abstracts on the Subcutaneous Depot Formulation of Pegnivacogin, a Nuclease-Stabilized RNA Aptamer, Direct Factor IXa Inhibitor and Part of the REG2 Anticoagulant System, at the American Heart Association (AHA)

Post Your Comments:

(Date:5/17/2013)... LUXEMBOURG , May 17, 2013 ConvaTec today announced that it ... Ken Berger , CEO, and Ed Borkowski ... AM ET live via telephone. To participate in the ... (877) 366-0267. To participate in the conference call outside the ... The conference ID is 72195398. Participants should dial in ...

(Date:5/17/2013)... 17, 2013 PENTAX Medical, a healthcare industry ... global leader in ultrasound imaging, recently announced renewed ... enable further innovation in the development of Endoscopic ... systems and PENTAX Medical endoscopic portfolio have formed ... EUS systems. This agreement will continue to grow ...

(Date:5/17/2013)... Mass. , May 17, 2013 Boston Scientific ... participate at the annual EuroPCR Scientific Program May 21-24 ... are pleased to present a particularly rich and diversified ... Keith Dawkins , M.D., global chief medical ... trials will be presented, including the NG PROMUS trial, ...

Breaking Medicine Technology:PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems 2 PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems 3 Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 2 Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 3 Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 4 Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 5 Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 6 Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 7 Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 8

[0] ConvaTec Announces 2013 First Quarter Earnings Call [0] PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems [0] Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013

... Accuray Incorporated (Nasdaq: ARAY ), a global ... management is scheduled to present at the JMP Securities Healthcare ... at 11:30 a.m. ET/8:30 a.m. PT. A live ... investor relations page of the Company,s Web site at ...

... Boston Scientific Corporation (NYSE: BSX ) ... under which Boston Scientific will acquire Asthmatx, Inc., a ... and markets a less-invasive, catheter-based bronchial thermoplasty procedure for ... to 8 million patients 18 years and older worldwide ...

Cached Medicine Technology:Accuray Incorporated to Speak at JMP Securities Healthcare Conference 2 Boston Scientific to Acquire Asthmatx 2 Boston Scientific to Acquire Asthmatx 3 Boston Scientific to Acquire Asthmatx 4 Boston Scientific to Acquire Asthmatx 5

Accuray Incorporated to Speak at JMP Securities Healthcare Conference Boston Scientific to Acquire Asthmatx

(Date:5/19/2013)... HealthDay Reporter , , SATURDAY, May 18 (HealthDay ... with Crohn,s disease overcome the fatigue and decreased ... according to new research. Extra vitamin D ... general fatigue, greater quality of life and the ... Tara Raftery, a research dietitian and doctoral candidate ...

(Date:5/19/2013)... in Minnesota have a great option to get in shape ... Fat Loss Formula. The best part is people can ... The product sells for $135 dollars and is an immediate ... http://altmanfitness.com/28-day-fat-loss-formula/ , “Bikini season is almost here. People may ... the 28 Day Fat Loss Formula they will be happy ...

(Date:5/19/2013)... May 19, 2013 Grinding your teeth ... losing sleep, or annoying your spouse. At the same ... CNY Central (“Snoring and Teeth Grinding Could Be a ... teeth grinding can be hard to prevent. Apparently, Obstructive ... and one of its symptoms is a habit of ...

(Date:5/19/2013)... (PRWEB) May 19, 2013 Fat Burning ... loss program that provides people with fat burning ... people order this Fat Burning Furnace package, people will ... that they can download quickly. The Fat Burning Furnace ... helps people build lean muscle mass. In addition, this ...

(Date:5/19/2013)... The Fat Loss Code program developed by ... that help people get in shape, and gain a healthy ... program also is a natural fat loss system that provides ... of this fat loss diet program claimed that The Fat ... people keep body fat off long-term. After Shawn Stevenson launched ...

Breaking Medicine News(10 mins):Health News:Extra Vitamin D May Ease Crohn's Symptoms, Study Finds 2 Health News:Extra Vitamin D May Ease Crohn's Symptoms, Study Finds 3 Health News:Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder 2 Health News:Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder 3 Health News:Fat Burning Diet | How “Fat Burning Furnace” Helps People Lose Their Weight Naturally And Fast – V-kool 2 Health News:Weight Loss Secrets | How “The Fat Loss Code” Helps People Gain A Healthy Life And Get In Shape - Health Review 2

[0] Extra Vitamin D May Ease Crohn's Symptoms, Study Finds [0] 28 Day Fat Loss Formula Offered To Minnesota Residents [0] Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder [0] Fat Burning Diet | How “Fat Burning Furnace” Helps People Lose Their Weight Naturally And Fast – V-kool [0] Weight Loss Secrets | How “The Fat Loss Code” Helps People Gain A Healthy Life And Get In Shape - Health Review

... The following is a statement from Georges C. ... the American Public Health Association:"The American Public Health ... Dr. Thomas Frieden as the new director of ... his tenure as New York City,s health commissioner, ...

... WASHINGTON , May 15 Americans United for ... the probable "short list" of President Obama,s Supreme Court ... the nation,s first national pro-life organization and the leading ... , , The comprehensive, concise ...

... Application to Offer Single Platform for AF Patient ... www.ecardio.com ) announced the launch of ... at Heart Rhythm 2009, the Annual Scientific Sessions ... an informatics solution that presents a longitudinal view ...

... Efforts to Expand Treatment Options for Patients with PKUNOVATO, ... BMRN ) announced today that it has received ... Rare Disorders (NORD), an organization dedicated to improving the ... presented on May 14 at NORD,s annual "Partners in ...

... Meanwhile, world health officials discuss strategy for a vaccine ... troubling sign that the swine flu outbreak has yet ... three New York City public schools were closed Thursday ... principal was in critical condition on a ventilator, according ...

... Mattar team to improve nation,s healthCARMEL, Ind., May 15 ... his weight loss journey with over 400 current and former ... the East Chalet at the Indianapolis Motor Speedway on Friday, ... track, but was struggling to keep up in his personal ...

APHA Applauds Choice of Frieden to Lead CDC Americans United for Life Announces Legal Prospectus on Probable Supreme Court Nominees eCardio Launches NEW Atrial Fibrillation Information System (AFIS(TM))BioMarin Receives 2009 Corporate Award for the Development of Kuvan Swine Flu Closes 3 Schools in NYC 400 People Join Panther Racing CEO and Physician to Celebrate Improved Health and Quality of Life

Used for stenting the urethra after hypospadias or epispadias repair and to provide post-operative drainage of the bladder. Supplied sterile in peel-open packages. Intended for one-time use....

... for temporary internal drainage ... to the bladder. Supplied ... Intended for one-time use. ... advised; C-Flex® and Sof-Flex® ...

... direct a .038 inch (0.97 ... a specific renal area. The ... stainless steel braid which imparts ... shaft. Supplied sterile in peel-open ...

Supplied sterile in peel-open packages. Intended for one-time use....

Medicine Products:

Zaontz Urethral Stents Multi-Length Stent Sets - C-Flex®Renal Access Cobra Catheter Movable Core Curved Safe-T-J® Wire Guides